Evidence map›Paper›PMID 38300308›Full record

ReviewJournal of cancer research and clinical oncology2024

Skeletal muscle extramedullary plasmacytoma transformed into plasmablastic plasmacytoma: a case report.

Shuang Zhang, Zheng Zhi, Jie Yang, Shumin Cao, Nan Wu, Lin Kang, Jing Zhao

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Journal of cancer research and clinical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Shuang Zhang *Department of Oncology, Hebei General Hospital, NO.348 Heping West Road, Xinhua District, Shijiazhuang City, 050051, Hebei Province, People's Republic of China.
Zheng Zhi *Department of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.
Jie YangDepartment of Oncology, Hebei General Hospital, NO.348 Heping West Road, Xinhua District, Shijiazhuang City, 050051, Hebei Province, People's Republic of China.
Shumin CaoDepartment of Oncology, Hebei General Hospital, NO.348 Heping West Road, Xinhua District, Shijiazhuang City, 050051, Hebei Province, People's Republic of China.
Nan WuDepartment of Oncology, Hebei General Hospital, NO.348 Heping West Road, Xinhua District, Shijiazhuang City, 050051, Hebei Province, People's Republic of China.
Lin KangDepartment of Oncology, Hebei General Hospital, NO.348 Heping West Road, Xinhua District, Shijiazhuang City, 050051, Hebei Province, People's Republic of China.
Jing ZhaoDepartment of Oncology, Hebei General Hospital, NO.348 Heping West Road, Xinhua District, Shijiazhuang City, 050051, Hebei Province, People's Republic of China. zzzjmail@163.com.
Hebei General Hospital · CNHebei Medical University · CNHebei North University · CNHebei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtramedullary plasmacytoma (EMP) is a rare plasma cell malignancy, especially when the tumor originates in skeletal muscle. Plasmablastic plasmacytoma is an anaplastic round cell tumor with highly malignancy and poor prognosis. To date, there have been no reports on the transformation of skeletal muscle EMP into plasmablastic plasmacytoma. Therefore, the diagnosis, treatment, and prognosis of cases of this pathologic transformation are unclear. CASE PRESENTATION: This article reports a case of an elderly male patient who presented with a painless mass in the right calf and was diagnosed with EMP by puncture pathology. Complete remission was obtained after sequential chemoradiotherapy. 6 months later, another puncture was performed due to plasmablastic plasmacytoma multiple distant metastases, and the pathology showed that EMP was transformed to plasmablastic plasmacytoma. Despite aggressive antitumor therapy, the disease continued to deteriorate, and the patient ultimately died of respiratory failure.

conclusionThe transformation of EMP into plasmablastic plasmacytoma is very rare, and its diagnosis and treatment require the participation of both experienced pathologists and clinicians. We report this case in order to raise clinicians' awareness of the diagnosis and treatment of EMP and its transformation to plasmablastic plasmacytoma, and to avoid misdiagnosis and underdiagnosis.

Indexed as

PlasmacytomaAgedChemoradiotherapyDeathHumansMaleMuscle, SkeletalPathologic Complete ResponseEMPGastrocnemiusPlasmablasticPlasmacytomaRadiotherapy

Identifiers

PMID38300308
PMCPMC10834611
OpenAlexW4391448661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.